Early insulinization to prevent diabetes progression - PubMed (original) (raw)

Review

. 2013 Aug;36 Suppl 2(Suppl 2):S190-7.

doi: 10.2337/dcS13-2014.

Affiliations

• PMID: 23882045
• PMCID: PMC3920803
• DOI: 10.2337/dcS13-2014

Review

Early insulinization to prevent diabetes progression

Itamar Raz et al. Diabetes Care. 2013 Aug.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Milestones in clinical research of early insulin therapy.

Similar articles

• Subcutaneous insulin order sets and protocols: effective design and implementation strategies.
  Maynard G, Wesorick DH, O'Malley C, Inzucchi SE; Society of Hospital Medicine Glycemic Control Task Force. Maynard G, et al. J Hosp Med. 2008 Sep;3(5 Suppl):29-41. doi: 10.1002/jhm.354. J Hosp Med. 2008. PMID: 18951386 Review. No abstract available.
• Insulin Therapy, Insulin Resistance and Vascular Dysfunction.
  Vázquez MC, Sobrevia L. Vázquez MC, et al. Curr Vasc Pharmacol. 2019;17(5):429-431. doi: 10.2174/157016111705190703103110. Curr Vasc Pharmacol. 2019. PMID: 31418345
• American College of Endocrinology position statement on inpatient diabetes and metabolic control.
  Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. Garber AJ, et al. Endocr Pract. 2004 Mar-Apr;10 Suppl 2:4-9. doi: 10.4158/EP.10.S2.4. Endocr Pract. 2004. PMID: 15251633 No abstract available.
• American College of Endocrinology position statement on inpatient diabetes and metabolic control.
  Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. Garber AJ, et al. Endocr Pract. 2004 Jan-Feb;10(1):77-82. doi: 10.4158/EP.10.1.77. Endocr Pract. 2004. PMID: 15251626 No abstract available.
• How to manage steroid diabetes in the patient with cancer.
  Oyer DS, Shah A, Bettenhausen S. Oyer DS, et al. J Support Oncol. 2006 Oct;4(9):479-83. J Support Oncol. 2006. PMID: 17080737 Review. No abstract available.

Cited by

• One-year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes.
  Taybani ZJ, Bótyik B, Gyimesi A, Katkó M, Várkonyi T. Taybani ZJ, et al. Endocrinol Diabetes Metab. 2023 Jan;6(1):e390. doi: 10.1002/edm2.390. Epub 2022 Dec 3. Endocrinol Diabetes Metab. 2023. PMID: 36461758 Free PMC article. Clinical Trial.
• From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.
  Mosenzon O, Del Prato S, Schechter M, Leiter LA, Ceriello A, DeFronzo RA, Raz I. Mosenzon O, et al. Cardiovasc Diabetol. 2021 Apr 28;20(1):92. doi: 10.1186/s12933-021-01281-y. Cardiovasc Diabetol. 2021. PMID: 33910583 Free PMC article. Review.
• Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update.
  Hanefeld M, Fleischmann H, Siegmund T, Seufert J. Hanefeld M, et al. Diabetes Ther. 2020 Aug;11(8):1645-1666. doi: 10.1007/s13300-020-00855-5. Epub 2020 Jun 20. Diabetes Ther. 2020. PMID: 32564335 Free PMC article. Review.
• Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home.
  Donihi AC. Donihi AC. Curr Diab Rep. 2017 Jul;17(7):52. doi: 10.1007/s11892-017-0876-1. Curr Diab Rep. 2017. PMID: 28573408 Review.
• High rates of diabetes reversal in newly diagnosed Asian Indian young adults with type 2 diabetes mellitus with intensive lifestyle therapy.
  Sarathi V, Kolly A, Chaithanya HB, Dwarakanath CS. Sarathi V, et al. J Nat Sci Biol Med. 2017 Jan-Jun;8(1):60-63. doi: 10.4103/0976-9668.198343. J Nat Sci Biol Med. 2017. PMID: 28250676 Free PMC article.

References

1. 1. Gerstein HC, Bosch J, Dagenais GR, et al. ORIGIN Trial Investigators Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012;367:319–328 - PubMed
2. 1. Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 1985;28:119–121 - PubMed
3. 1. Poitout V, Robertson RP. Minireview: Secondary beta-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002;143:339–342 - PubMed
4. 1. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008;29:351–366 - PMC - PubMed
5. 1. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G. Glucolipotoxicity of the pancreatic beta cell. Biochimic Biophys Acta 2010; 1801:289–298 - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information